Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis

NCT03331835 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT03331835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03331835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis
Lead sponsor
LEO Pharma
Phase
Phase 4
Overall status
Completed
Start date
November 3, 2017
Completion date
March 21, 2019
Enrollment
210 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris